Freeman Chris, Chief Commercial Officer of Guardant Health, Inc. ($GH), sold about $3.2 million worth of company shares through 11 open market transactions over the past year. His most recent sale occurred on December 5, 2025. These sales rank 2,584th among 11,678 individual insiders in our database, where the average is $8.6 million across about 6.4 transactions per person. Chris made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 5091 | $0.00 | 10,339.0000 | 131,170,441 | 32.99% | 0.00% |
| April 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 2526 | $0.00 | 15,158.0000 | 131,170,441 | 14.28% | 0.00% |
| April 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1667 | $0.00 | 3,335.0000 | 131,170,441 | 33.33% | 0.00% |
| April 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1929 | $0.00 | 3,857.0000 | 131,170,441 | 33.34% | 0.00% |
| April 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 4750 | $91.15 | 60,034.0000 | 131,170,441 | 7.33% | 0.00% |
| April 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 5091 | $0.00 | 64,784.0000 | 131,170,441 | 8.53% | 0.00% |
| April 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 2526 | $0.00 | 59,693.0000 | 131,170,441 | 4.42% | 0.00% |
| April 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1929 | $0.00 | 55,500.0000 | 131,170,441 | 3.60% | 0.00% |
| April 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1667 | $0.00 | 57,167.0000 | 131,170,441 | 3.00% | 0.00% |
| March 15, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1402 | $0.00 | 1,402.0000 | 131,170,441 | 50.00% | 0.00% |
| March 15, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Performance-Based Restricted Stock Units | 15426 | $0.00 | 0.0000 | 131,170,441 | 100.00% | 0.01% |
| March 15, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 7127 | $85.49 | 53,571.0000 | 131,170,441 | 11.74% | 0.01% |
| March 15, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1402 | $0.00 | 60,698.0000 | 131,170,441 | 2.36% | 0.00% |
| March 15, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 15426 | $0.00 | 59,296.0000 | 131,170,441 | 35.16% | 0.01% |
| March 11, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | A | Restricted Stock Units | 18744 | $0.00 | 18,744.0000 | 131,170,441 | 9999.99% | 0.01% |
| Jan. 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Performance-Based Restricted Stock Units | 15428 | $0.00 | 15,428.0000 | 126,041,089 | 50.00% | 0.01% |
| Jan. 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1928 | $0.00 | 28,723.0000 | 126,041,089 | 7.20% | 0.00% |
| Jan. 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 15428 | $0.00 | 44,151.0000 | 126,041,089 | 53.71% | 0.01% |
| Jan. 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1667 | $0.00 | 45,818.0000 | 126,041,089 | 3.78% | 0.00% |
| Jan. 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 5688 | $0.00 | 51,506.0000 | 126,041,089 | 12.41% | 0.00% |
| Jan. 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 2526 | $0.00 | 54,032.0000 | 126,041,089 | 4.90% | 0.00% |
| Jan. 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 10162 | $102.14 | 43,870.0000 | 126,041,089 | 18.81% | 0.01% |
| Jan. 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Performance-Based Restricted Stock Units | 5688 | $0.00 | 21,116.0000 | 126,041,089 | 21.22% | 0.00% |
| Jan. 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1667 | $0.00 | 5,002.0000 | 126,041,089 | 25.00% | 0.00% |
| Jan. 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1928 | $0.00 | 5,786.0000 | 126,041,089 | 24.99% | 0.00% |
| Jan. 1, 2026 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 2526 | $0.00 | 17,684.0000 | 126,041,089 | 12.50% | 0.00% |
| Dec. 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1402 | $0.00 | 2,804.0000 | 126,041,089 | 33.33% | 0.00% |
| Dec. 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 594 | $102.67 | 26,795.0000 | 126,041,089 | 2.17% | 0.00% |
| Dec. 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1402 | $0.00 | 27,389.0000 | 126,041,089 | 5.40% | 0.00% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | S | Common Stock | 228 | $106.63 | 55,373.0000 | 126,041,089 | 0.41% | 0.00% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | S | Common Stock | 2964 | $106.71 | 25,987.0000 | 126,041,089 | 10.24% | 0.00% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | S | Common Stock | 400 | $105.99 | 28,951.0000 | 126,041,089 | 1.36% | 0.00% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | S | Common Stock | 6555 | $103.97 | 29,351.0000 | 126,041,089 | 18.26% | 0.01% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | S | Common Stock | 3414 | $103.25 | 35,906.0000 | 126,041,089 | 8.68% | 0.00% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | S | Common Stock | 11969 | $102.09 | 39,320.0000 | 126,041,089 | 23.34% | 0.01% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | S | Common Stock | 4084 | $101.40 | 51,289.0000 | 126,041,089 | 7.38% | 0.00% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | S | Common Stock | 244 | $104.10 | 55,601.0000 | 126,041,089 | 0.44% | 0.00% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | S | Common Stock | 372 | $103.48 | 55,845.0000 | 126,041,089 | 0.66% | 0.00% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | S | Common Stock | 744 | $102.31 | 56,217.0000 | 126,041,089 | 1.31% | 0.00% |
| Dec. 5, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | S | Common Stock | 478 | $101.43 | 56,961.0000 | 126,041,089 | 0.83% | 0.00% |
| Oct. 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 5740 | $62.65 | 57,439.0000 | 123,421,441 | 9.09% | 0.00% |
| Oct. 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 9954 | $0.00 | 63,179.0000 | 123,421,441 | 18.70% | 0.01% |
| Oct. 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 9954 | $0.00 | 20,210.0000 | 123,421,441 | 33.00% | 0.01% |
| Oct. 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1668 | $0.00 | 6,669.0000 | 123,421,441 | 20.01% | 0.00% |
| Oct. 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1668 | $0.00 | 53,225.0000 | 123,421,441 | 3.24% | 0.00% |
| Oct. 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1928 | $0.00 | 51,557.0000 | 123,421,441 | 3.88% | 0.00% |
| Oct. 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1928 | $0.00 | 7,714.0000 | 123,421,441 | 20.00% | 0.00% |
| Sept. 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 594 | $54.79 | 49,629.0000 | 123,421,441 | 1.18% | 0.00% |
| Sept. 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1402 | $0.00 | 50,223.0000 | 123,421,441 | 2.87% | 0.00% |
| Sept. 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1402 | $0.00 | 4,206.0000 | 123,421,441 | 25.00% | 0.00% |
| July 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1667 | $0.00 | 8,337.0000 | 123,421,441 | 16.66% | 0.00% |
| July 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1929 | $0.00 | 48,686.0000 | 123,421,441 | 4.13% | 0.00% |
| July 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1929 | $0.00 | 9,642.0000 | 123,421,441 | 16.67% | 0.00% |
| July 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 1532 | $50.71 | 48,821.0000 | 123,421,441 | 3.04% | 0.00% |
| July 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1667 | $0.00 | 50,353.0000 | 123,421,441 | 3.42% | 0.00% |
| June 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1402 | $0.00 | 5,608.0000 | 123,421,441 | 20.00% | 0.00% |
| June 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 4879 | $0.00 | 0.0000 | 123,421,441 | 100.00% | 0.00% |
| June 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 2675 | $49.29 | 46,757.0000 | 123,421,441 | 5.41% | 0.00% |
| June 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1402 | $0.00 | 49,432.0000 | 123,421,441 | 2.92% | 0.00% |
| June 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 4879 | $0.00 | 48,030.0000 | 123,421,441 | 11.31% | 0.00% |
| April 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1928 | $0.00 | 11,571.0000 | 123,421,441 | 14.28% | 0.00% |
| April 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1928 | $0.00 | 41,731.0000 | 123,421,441 | 4.84% | 0.00% |
| April 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1667 | $0.00 | 43,398.0000 | 123,421,441 | 3.99% | 0.00% |
| April 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 1106 | $42.47 | 42,292.0000 | 123,421,441 | 2.55% | 0.00% |
| April 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1667 | $0.00 | 10,004.0000 | 123,421,441 | 14.28% | 0.00% |
| March 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 387 | $42.89 | 39,803.0000 | 123,421,441 | 0.96% | 0.00% |
| March 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1401 | $0.00 | 7,010.0000 | 123,421,441 | 16.66% | 0.00% |
| March 15, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1401 | $0.00 | 40,190.0000 | 123,421,441 | 3.61% | 0.00% |
| March 12, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | A | Stock Option (Right to Buy) | 23145 | $0.00 | 23,145.0000 | 123,421,441 | 9999.99% | 0.02% |
| March 12, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | A | Restricted Stock Units | 15430 | $0.00 | 15,430.0000 | 123,421,441 | 9999.99% | 0.01% |
| March 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Performance-Based Restricted Stock Units | 5686 | $0.00 | 28,438.0000 | 123,421,441 | 16.66% | 0.00% |
| March 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 5686 | $0.00 | 40,355.0000 | 123,421,441 | 16.40% | 0.00% |
| March 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 1566 | $42.55 | 38,789.0000 | 123,421,441 | 3.88% | 0.00% |
| Jan. 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1667 | $0.00 | 35,852.0000 | 0 | 4.88% | 0.00% |
| Jan. 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1928 | $0.00 | 34,185.0000 | 0 | 5.98% | 0.00% |
| Jan. 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 1183 | $30.55 | 34,669.0000 | 0 | 3.30% | 0.00% |
| Jan. 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1928 | $0.00 | 13,499.0000 | 0 | 12.50% | 0.00% |
| Jan. 1, 2025 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1667 | $0.00 | 11,671.0000 | 0 | 12.50% | 0.00% |
| Dec. 15, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1402 | $0.00 | 32,854.0000 | 0 | 4.46% | 0.00% |
| Dec. 15, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 597 | $34.76 | 32,257.0000 | 0 | 1.82% | 0.00% |
| Dec. 15, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1402 | $0.00 | 8,411.0000 | 0 | 14.29% | 0.00% |
| Nov. 8, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | A | Stock Option (Right to Buy) | 45246 | $0.00 | 45,246.0000 | 0 | 9999.99% | 0.00% |
| Nov. 8, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | A | Restricted Stock Units | 30164 | $0.00 | 30,164.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 6569 | $0.00 | 35,072.0000 | 0 | 23.05% | 0.00% |
| Oct. 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 6569 | $0.00 | 13,338.0000 | 0 | 33.00% | 0.00% |
| Oct. 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1929 | $0.00 | 15,427.0000 | 0 | 11.11% | 0.00% |
| Oct. 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 3620 | $22.12 | 31,452.0000 | 0 | 10.32% | 0.00% |
| Oct. 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1929 | $0.00 | 28,503.0000 | 0 | 7.26% | 0.00% |
| Sept. 15, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1402 | $0.00 | 27,171.0000 | 0 | 5.44% | 0.00% |
| Sept. 15, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 597 | $26.79 | 26,574.0000 | 0 | 2.20% | 0.00% |
| Sept. 15, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1402 | $0.00 | 9,813.0000 | 0 | 12.50% | 0.00% |
| July 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1928 | $0.00 | 17,356.0000 | 0 | 10.00% | 0.00% |
| July 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1928 | $0.00 | 26,527.0000 | 0 | 7.84% | 0.00% |
| July 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 758 | $28.26 | 25,769.0000 | 0 | 2.86% | 0.00% |
| June 15, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 4879 | $0.00 | 4,879.0000 | 0 | 50.00% | 0.00% |
| June 15, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 4879 | $0.00 | 21,946.0000 | 0 | 28.59% | 0.00% |
| June 15, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 5523 | $0.00 | 27,469.0000 | 0 | 25.17% | 0.00% |
| June 15, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 2870 | $30.21 | 24,599.0000 | 0 | 10.45% | 0.00% |
| June 15, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 5523 | $0.00 | 11,215.0000 | 0 | 33.00% | 0.00% |
| April 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | Common Stock | 531 | $20.25 | 15,971.0000 | 0 | 3.22% | 0.00% |
| April 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Common Stock | 1929 | $0.00 | 16,502.0000 | 0 | 13.24% | 0.00% |
| April 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | Restricted Stock Units | 1929 | $0.00 | 19,284.0000 | 0 | 9.09% | 0.00% |
| Jan. 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | F | COMMON STOCK | 634 | $27.05 | 14,573.0000 | 0 | 4.17% | 0.00% |
| Jan. 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | COMMON STOCK | 1928 | $0.00 | 15,207.0000 | 0 | 14.52% | 0.00% |
| Jan. 1, 2024 | Guardant Health, Inc. | $GH | Freeman Chris | Chief Commercial Officer | M | RESTRICTED STOCK UNITS | 1928 | $0.00 | 21,213.0000 | 0 | 8.33% | 0.00% |